聚焦超声介导血脑屏障破坏增强脑肿瘤治疗药物递送
胶质母细胞瘤是成人最常见的颅内恶性肿瘤,预后差,化疗是重要治疗手段,但血脑屏障阻碍药物进入肿瘤组织。聚焦超声利用声空化效应机械性破坏血管内皮,从而增强化疗药物和生物制剂的递送。本文综述了评估聚焦超声增强肿瘤治疗药物递送的临床前和临床研究,并展望了未来方向。
要点
- 聚焦超声通过声空化效应机械破坏血脑屏障,增强药物递送。
- 该技术有望提高胶质母细胞瘤化疗和生物制剂的疗效。
- 临床前和临床研究支持其安全性和有效性,但需进一步优化。
核心结论
- 聚焦超声介导的血脑屏障破坏是一种有前景的策略,可增强胶质母细胞瘤的治疗药物递送。
研究设计与样本
- 综述临床前和临床研究,评估聚焦超声增强肿瘤治疗药物递送的生物物理基础和疗效。
主要发现
- 聚焦超声利用声空化效应机械破坏血管内皮,从而破坏血脑屏障。
- 该技术可增强细胞毒性化疗药物和新型生物制剂的递送。
临床怎么用
- 聚焦超声可能作为辅助手段,提高胶质母细胞瘤药物递送的效率和安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glioblastoma is the most common intracranial malignancy in adults and carries a poor prognosis. Chemotherapeutic treatment figures prominently in the management of primary and recurrent disease. However, the blood-brain barrier presents a significant and formidable impediment to the entry of oncotherapeutic compounds to target tumor tissue. Several strategies have been developed to effect disruption of the blood-brain barrier and in turn enhance the efficacy of cytotoxic chemotherapy, as well as newly developed biologic agents. Focused ultrasonography is one such treatment modality, using acoustic cavitation of parenterally administered microbubbles to mechanically effect disruption of the vascular endothelium. We review and discuss the preclinical and clinical studies evaluating the biophysical basis for, and efficacy of, focused ultrasonography in the enhancement of oncotherapeutic agent delivery. Further, we provide some perspectives regarding future directions for the role of focused ultrasound in facilitating and improving the safe and effective delivery of oncotherapeutic agents in the treatment of glioblastoma.
引用
- Zaki Ghali MG, Srinivasan VM, Kan P, et al. Focused Ultrasonography-Mediated Blood-Brain Barrier Disruption in the Enhancement of Delivery of Brain Tumor Therapies. World Neurosurg. 2019. PMID: 31323404. doi:10.1016/j.wneu.2019.07.096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。